47 results on '"Brigida, Immacolata"'
Search Results
2. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency
3. Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency
4. Lentiviral-Mediated Gene Therapy for the Treatment of Adenosine Deaminase 2 Deficiency
5. Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency
6. Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency
7. C1-3 Immune reconstitution after gene therapy for adenosine deaminase severe combined immunodeficiency (ADA-SCID)
8. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function
9. FRI0540 A NOVEL AUTOINFLAMMATORY DISEASE CHARACTERIZED BY NEONATAL-ONSET CYTOPENIA WITH AUTOINFLAMMATION, RASH, AND HEMOPHAGOCYTOSIS (NOCARH) DUE TO ABERRANT CDC42 FUNCTION
10. A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency
11. Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies
12. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study
13. Next-Generation Sequencing Reveals A JAGN1 Mutation in a Syndromic Child With Intermittent Neutropenia
14. Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies
15. Effect of Methyl-β-Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles
16. First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia
17. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation
18. T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency
19. First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature
20. Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure
21. Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency
22. The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment
23. Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection
24. ACTIVATING N-RAS SOMATIC MUTATION CAUSES AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME
25. NEXT GENERATION SEQUENCING FOR THE IDENTIFICATION OF MAGT1 DELETIONAL EVENT ASSOCIATED WITH KAPOSI SARCOMA
26. A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation
27. Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency
28. B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome
29. B-cell development and functions and therapeutic options in adenosine deaminase–deficient patients
30. Biological Evaluation of Hyperforin and Its Hydrogenated Analogue on Bacterial Growth and Biofilm Production
31. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity
32. T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation
33. Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy
34. HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines
35. Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID
36. Autoimmune Dysregulation and Purine Metabolism in Adenosine Deaminase Deficiency
37. T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression
38. Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency
39. In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency
40. The infusion of suicide gene-modified donor T cells after hematopoietic stem cell transplantation prompts thymic renewal in adult patients by an IL-7 dependent mechanism (169.4)
41. Integration profile of retroviral vector in gene therapy treated patients is cell‐specific according to gene expression and chromatin conformation of target cell
42. Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency
43. Thymic Renewal and Anti-Leukemic Effect In Adults After Haploidentical Transplantation and Donor T Cell Suicide Gene Therapy
44. Study of peripheral tolerance in ADA SCID patients after different treatments (143.36)
45. Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID
46. Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
47. Autoimmunity in ADA Deficiency-New Insights 381 from Human and Mouse Studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.